Protagonist Therapeutics (PTGX)
(Delayed Data from NSDQ)
$28.23 USD
-0.04 (-0.14%)
Updated May 10, 2024 04:00 PM ET
After-Market: $28.24 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.68 | -15.03% |
Earnings Summary
For their last quarter, Protagonist Therapeutics (PTGX) reported earnings of $3.26 per share, beating the Zacks Consensus Estimate of $2.51 per share. This reflects a positive earnings surprise of 29.88%. Look out for PTGX's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.68 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for PTGX
Wall Street Analysts Think Protagonist Therapeutics (PTGX) Could Surge 48.38%: Read This Before Placing a Bet
PTGX: What are Zacks experts saying now?
Zacks Private Portfolio Services